CLBT Cellebrite DI Ltd

  1. Stocks
  2. Technology
  3. NASDAQ: CLBT

Price (delayed)

$11.125

Market cap

$2.75B

P/E Ratio

48.37

Dividend/share

N/A

EPS

$0.23

Enterprise value

$2.64B

?
Relative Growth: Rel. Growth: 71
Relative Strength: Rel. Strength: 13
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 91
Highlights
The equity is up by 32% year-on-year and by 5% since the previous quarter
CLBT's revenue is up by 18% YoY and by 3.6% QoQ
The net income has surged by 139% year-on-year but it has declined by 18% since the previous quarter
Cellebrite DI's EPS has surged by 133% YoY but it has decreased by 18% QoQ
The debt has grown by 4% YoY
Sector: Technology
Industry: Software - Infrastructure
Website: https://www.cellebrite.com
Peers: PHR PHUN

Key stats

What are the main financial stats of CLBT

CLBT stock price

How has the Cellebrite DI stock price performed over time
Intraday
-0.13%
1 week
3.1%
1 month
-4.26%
1 year
-40.71%
YTD
-38.3%
QTD
-1.2%

Financial performance

How have Cellebrite DI's revenue and profit performed over time
Revenue
$514.29M
Gross profit
$426.66M
Operating income
$55.86M
Net income
$58.76M
Gross margin
83%
Net margin
11.4%
The net income has surged by 139% year-on-year but it has declined by 18% since the previous quarter
The net margin has soared by 133% YoY but it has contracted by 21% from the previous quarter
Cellebrite DI's operating margin has decreased by 23% YoY and by 15% from the previous quarter
CLBT's revenue is up by 18% YoY and by 3.6% QoQ

Price vs fundamentals

How does CLBT's price correlate with its fundamentals

Growth

What is Cellebrite DI's growth rate over time

Valuation

What is Cellebrite DI stock price valuation
P/E
48.37
P/B
5.1
P/S
5.36
EV/EBIT
47.2
EV/EBITDA
33.62
EV/Sales
5.13
Cellebrite DI's EPS has surged by 133% YoY but it has decreased by 18% QoQ
The stock's price to earnings (P/E) is 11% less than its last 4 quarters average of 54.4
The stock's price to book (P/B) is 37% less than its last 4 quarters average of 8.1
The equity is up by 32% year-on-year and by 5% since the previous quarter
The P/S is 35% below the last 4 quarters average of 8.2 and 18% below the 5-year quarterly average of 6.5
CLBT's revenue is up by 18% YoY and by 3.6% QoQ

Efficiency

How efficient is Cellebrite DI business performance
CLBT's return on assets has surged by 129% year-on-year but it is down by 23% since the previous quarter
CLBT's ROE has soared by 128% YoY but it is down by 23% from the previous quarter
Cellebrite DI's return on sales has decreased by 23% YoY and by 15% QoQ
CLBT's return on invested capital is down by 14% year-on-year and by 11% since the previous quarter

Dividends

What is CLBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLBT.

Financial health

How did Cellebrite DI financials performed over time
The total assets is 118% more than the total liabilities
The total assets has grown by 26% YoY and by 4.4% from the previous quarter
Cellebrite DI's total liabilities has increased by 20% YoY and by 3.3% from the previous quarter
The debt is 96% less than the equity
The equity is up by 32% year-on-year and by 5% since the previous quarter
The debt to equity has declined by 20% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.